Showing results (1341-1350 of 2,482) with videos related to

Sort By:
Pageof 249
Clinical and Translational Science|October 3, 2023
Bioequivalence study of dacomitinib and Vizimpro® in healthy Chinese volunteers under fasting and fed conditions: A randomized, open-label, single-dose, crossover trialXiaojia Yang, Jinfang Li, Taihui Zhang, et al.
Clinical and Translational Science|September 28, 2023
A first-in-human phase I study of SHR-1906, a humanized monoclonal antibody against connective tissue growth factor, in healthy participantsLin-Lin Song, Hai-Yan Zhou, Pan-Pan Ye, et al.
Clinical and Translational Science|September 22, 2023
Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolismYuen Yi Hon, Jie Wang, Henrietta Abodakpi, et al.
Clinical and Translational Science|July 6, 2023
A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products among Swissmedic, European Medicines Agency, and US Food and Drug AdministrationUlrich-P Rohr, Mario Iovino, Leonie Rudofsky, et al.
Clinical and Translational Science|June 29, 2023
Data Management 101 for drug developers: A peek behind the curtainBryan Oronsky, Erica Burbano, Meaghan Stirn, et al.
Clinical and Translational Science|July 15, 2023
Prevalence and utility of pharmacokinetic data in preclinical studies of mRNA cancer vaccinesGillie A Roth, Bianca Vora, Chloe Kim, et al.
Clinical and Translational Science|July 14, 2023
Clinical outcomes of generic versus brand-name clopidogrel for secondary prevention in patients with acute myocardial infarction: A nationwide cohort studyCze Ci Chan, Ying-Chang Tung, Kuang-Tso Lee, et al.
Clinical and Translational Science|July 7, 2023
Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institutionKelsey J Cook, Victoria Grusauskas, Lucy Gloe, et al.
Clinical and Translational Science|June 22, 2023
A phase I randomized, double-blinded, placebo-controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjectsJason Lickliter, Shuang Wang, Wenxin Zhang, et al.
Clinical and Translational Science|June 22, 2023
DNA methyltransferase inhibitor exposure-response: Challenges and opportunitiesAmanda B Kagan, Dominique A Garrison, Nicole M Anders, et al.
Pageof 249